ÁÁ
Ángel Álvarez-Prado
Luxembourg Institute of Health (LIH)
Translational Cancer Immunogenomics Group Leader
Presentation
Dr Álvarez-Prado is a cancer biologist investigating how genomic alterations shape anti-tumoral immunity and, in turn, influence responses to therapy for brain metastatic cancer.
Loading



